NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

Redhill Biopharma Ltd.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERRDHL
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / RDHL COVERAGE

What’s moving Redhill Biopharma Ltd. now

Current reporting with the operating signal separated from the noise.

01
RedHill Biopharma Ltd.: RedHill Divests Talicia to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

RedHill Biopharma Ltd.: RedHill Divests Talicia to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

The story matters when it changes Redhill Biopharma Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Redhill Biopharma Ltd Stock Guidance

Redhill Biopharma Ltd Stock Guidance

Investors are testing whether Redhill Biopharma Ltd.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Benign Growth For RedHill Biopharma Ltd. (NASDAQ:RDHL) Underpins Stock's 41% Plummet

Benign Growth For RedHill Biopharma Ltd. (NASDAQ:RDHL) Underpins Stock's 41% Plummet

Investors are testing whether Redhill Biopharma Ltd.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
RedHill Biopharma Ltd.'s (NASDAQ:RDHL) market cap dropped US$146m last week; Individual investors bore the brunt

RedHill Biopharma Ltd.'s (NASDAQ:RDHL) market cap dropped US$146m last week; Individual investors bore the brunt

The story matters when it changes Redhill Biopharma Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest RDHL filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

6-KOfficial SEC filingFiled 2026-09-01 · Period 2026-09-01SEC ↗6-KOfficial SEC filingFiled 2026-08-31 · Period 2026-08-31SEC ↗6-KOfficial SEC filingFiled 2026-08-07 · Period 2026-08-07SEC ↗6-KOfficial SEC filingFiled 2026-08-06 · Period 2026-08-06SEC ↗6-KOfficial SEC filingFiled 2026-07-28 · Period 2026-07-28SEC ↗424B3Official SEC filingFiled 2026-07-14SEC ↗EFFECTOfficial SEC filingFiled 2026-07-13SEC ↗4Official SEC filingFiled 2026-07-13 · Period 2026-07-10SEC ↗
EARNINGS / QUARTERLY TRACKER

Redhill Biopharma Ltd., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.